A comprehensive screening platform for aerosolizable protein formulations for intranasal and pulmonary drug delivery
Martina Röhm(Universität Ulm), Katharina Schindowski(University of Applied Sciences Biberach), Viktoria Kramer(University of Applied Sciences Biberach), Frank Maigler(University of Applied Sciences Biberach), Otmar Schmid(German Center for Lung Research), Stefan Carle(Boehringer Ingelheim (Germany)), J Flamm(University of Applied Sciences Biberach), Chrystelle Mavoungou(University of Applied Sciences Biberach)
Cited by 55
Related Papers
Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa
|Pharmaceutics|2018|415
Alzheimer's Disease-Like Tau Neuropathology Leads to Memory Deficits and Loss of Functional Synapses in a Novel Mutated Tau Transgenic Mouse without Any Motor Deficits
|American Journal Of Pathology|2006|383
Alternative Excipients for Protein Stabilization in Protein Therapeutics: Overcoming the Limitations of Polysorbates
|Pharmaceutics|2022|93
An in-depth examination of fatty acid solubility limits in biotherapeutic protein formulations containing polysorbate 20 and polysorbate 80
|International Journal of Pharmaceutics|2020|47